BRCA1 and neoplasm: In arm B, 74% of patients had unknown BRCA1/2 status (26% were BRCA1/2 negative); 49% and 51% had triple-negative and HR+ disease, respectively; and 40% had more than two tumor sites (liver metastasis, 60%).